Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Quantum-Si to Present at the 42nd Annual Cowen Health Care Conference


February 18, 2022--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences tools company commercializing single molecule protein sequencing, today announced that it will be participating virtually in the 42nd Annual Cowen Health Care Conference.

Quantum-Si's management is scheduled to present virtually on Tuesday, March 8, 2022 at 2:10 pm ET.

A live webcast of the event will be available in the Events & Presentations section of the Quantum-Si investor website. A replay will be available on the Company's website following the event.

About Quantum-Si Incorporated

Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.


These press releases may also interest you

at 11:56
The Next Level Deep Plane Face and Neck Lift: A Revolutionary Procedure for Natural and Long-Lasting Results
As the demand for cosmetic procedures continues to rise, patients are seeking more advanced and effective options for achieving a youthful and rejuvenated appearance. In response to this, Dr. Ronald Demeo has introduced the Next Level Deep Plane Face...

at 11:50
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited)...

at 11:34
Report from Annual General Meeting of Vitrolife AB (publ)
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare Earns Recognition as One of the World's Best Digital Health Companies, Earns Five Top Workplace Awards
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....

at 11:16
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market...

at 11:15
Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced the approval to expand the use of vebreltinib (also referred...

More news about Health...


News published on and distributed by: